Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
ORGS - Orgenesis Inc.
Market Cap 30.61M P/E - EPS this Y - Ern Qtrly Grth -
Income -45.66M Forward P/E 1.77 EPS next Y - 50D Avg Chg -13.00%
Sales 529k PEG - EPS past 5Y - 200D Avg Chg -31.00%
Dividend N/A Price/Book 1.09 EPS next 5Y - 52W High Chg -59.00%
Recommedations 2.00 Quick Ratio 0.01 Shares Outstanding 34.38M 52W Low Chg 10.00%
Insider Own 29.02% ROA -41.81% Shares Float 27.17M Beta -
Inst Own 6.59% ROE -324.61% Shares Shorted/Prior 288.11K/299.69K Price 1.08
Gross Margin - Profit Margin - Avg. Volume 29,190 Target Price -
Oper. Margin -6,333.33% Earnings Date Aug 9 Volume 14,847 Change -2.70%
Healthcare | Biotechnology | United States
About Orgenesis Inc.

Orgenesis Inc., a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. The company also provides development services, including regulatory services, pre-clinical studies, intellectual property services, and GMP process translation, as well as support services; hospital services; cell process development services; and distributed cell processing services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland.

Orgenesis Inc. News
06:00 AM Orgenesis Provides Business Update for the First Quarter of 2024
04/15/24 Orgenesis Provides Year End Business Update
04/10/24 Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility
03/18/24 Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference
03/13/24 Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes
03/04/24 Orgenesis Inc. Announces $2.3 Million Private Placement
02/29/24 Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing
01/31/24 EXCLUSIVE: Orgenesis Acquires Control of Octomera, Takes One Step Closer To Progressing Its Decentralized Immuno-Oncology Portfolio To Clinic
01/31/24 Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic
11/22/23 Analysts Expect Orgenesis Inc. (NASDAQ:ORGS) To Breakeven Soon
11/14/23 Orgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TM
11/13/23 Orgenesis Provides Business Update for the Third Quarter of 2023
11/08/23 Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct Offering
11/02/23 Orgenesis Announces Expanded Partnership Between Octomera and UC Davis Through CIRM Grant Funding
10/30/23 Orgenesis Announces Withdrawal of Proposed Public Offering
10/30/23 Orgenesis Announces Proposed Underwritten Public Offering
07:00 AM CGT Global and Octomera Enter Agreement to Expand Cell & Gene Therapy Development and Patient Access Across the United States
09/06/23 Cell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard Bauer, Joins Orgenesis Business, Octomera, to Drive Continued Expansion of POCare Facilities and Service Support
08/28/23 Is Orgenesis (ORGS) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap
08/28/23 Orgenesis Inc (ORGS): A Deep Dive into Its Performance Potential
ORGS Chatroom

User Image Stock_Titan Posted - 10 hours ago

$ORGS Orgenesis Provides Business Update for the First Quarter of 2024 https://www.stocktitan.net/news/ORGS/orgenesis-provides-business-update-for-the-first-quarter-of-b8dzuu83hj14.html

User Image ktks Posted - 1 week ago

$ORGS brewing soon like $GME?

User Image Murphy2011 Posted - 1 week ago

$IBRX my 4th pharma position after $NBRVF $NVAX $ORGS i should stop that ☺️

User Image Capital_Gains_X Posted - 04/30/24

$ORGS taking a small position here...

User Image techvested Posted - 04/25/24

$ASPU $RMNI $ORGS All three interesting but with money OUTFLOWS from stocks ACCELERATING, small caps will suffer most. No need to FOMO

User Image DonCorleone77 Posted - 04/22/24

$ORGS Orgenesis files $100M mixed securities shelf

User Image VrtcIl Posted - 1 month ago

$ORGS still gaining momentum towards 1$. The upward trend is supported by consistent higher highs and higher lows, with notable volume signaling increased buying interest. Price: 0.62 Float: 26.2M Short Float: 1.1 % 💰 Dollar Volume: 0.3K ℹ️ USA | Biotechnology

User Image Stock_Titan Posted - 1 month ago

$ORGS Orgenesis Provides Year End Business Update https://www.stocktitan.net/news/ORGS/orgenesis-provides-year-end-business-nztx37y3mw71.html

User Image SqueezeRib Posted - 1 month ago

$ORGS 👀

User Image Sweety21 Posted - 1 month ago

$ORGS

User Image MadMaverick Posted - 1 month ago

Mr.SLP LIVESTREAM TRADES ✅ $LASE | +15% potential ✅ $SPY | +50% potential WATCHLIST RECAP ✅ $ADIL | +47% potential ✅ $ORGS | +10% potential ✅ $IFBD | +4% potential

User Image Geradin Posted - 1 month ago

⚡AFTERNOON WATCHLIST⚡ $MRIN Above .80 🎯 .86/.90 🛑 .76 $ADIL Above 2.10 🎯 2.30/2.50 🛑 1.95 $ORGS Above .55 🎯 .58/.62 🛑 .52 $IFBD Above 5.60 🎯 5.80/6.00 🛑 5.40 Note: These are trade ideas based on break-out levels, once they hit entry & start moving up, I would think about raising your stops to protect your profits and protect your downside :). I personally trade these either on the 2 or 3 min chart, waiting for a candle to close over our entry.

User Image Palmettoweed Posted - 1 month ago

$ORGS more big news on tuesday

User Image Sweety21 Posted - 1 month ago

$ORGS

User Image MadMaverick Posted - 1 month ago

⚡AFTERNOON WATCHLIST⚡ $MRIN Above .80 🎯 .86/.90 🛑 .76 $ADIL Above 2.10 🎯 2.30/2.50 🛑 1.95 $ORGS Above .55 🎯 .58/.62 🛑 .52 $IFBD Above 5.60 🎯 5.80/6.00 🛑 5.40 Note: These are trade ideas based on break-out levels, once they hit entry & start moving up, I would think about raising your stops to protect your profits and protect your downside :). I personally trade these either on the 2 or 3 min chart, waiting for a candle to close over our entry.

User Image SwimmingZoo Posted - 1 month ago

$ORGS Are we stuck ?

User Image KyleRitz Posted - 1 month ago

$ORGS loaded up @.60

User Image FeliciaMath Posted - 1 month ago

$ORGS i should not have sold this so soon. would've made 100% gain if i was more patient. lesson learned.

User Image debbiekatz Posted - 1 month ago

$orgs just hit .88 - another doubler for team getting in at .42 for 110% gain. posted here at .44 for 100% gain.

User Image techvested Posted - 1 month ago

$ORGS I lost my nerve, sold out. i like the business, just haven't had time to do fundamental analysis

User Image Koldkash Posted - 1 month ago

$ORGS added 17k shares here

User Image jamestocklover Posted - 1 month ago

$VHAI Here is one of the great news. We should see new contracts coming in soon. $JAGX is trending $ORGS uptrend after asset purchase news https://finance.yahoo.com/news/vocodia-launches-pilot-program-major-120000442.html

User Image VrtcIl Posted - 1 month ago

Do not chase $ORGS and wait for consolidations to enter with defined risk. Monitoring the chart during consolidation phases can offer more controlled and calculated trades. Price: 0.86 Float: 26.2M Short Float: 1.1 % 💰 Dollar Volume: 182.1K ℹ️ USA | Biotechnology

User Image Koldkash Posted - 1 month ago

$ORGS .52’s looking money follow For my gem picks !

User Image Nedwin513 Posted - 1 month ago

$ORGS Pings HOD

User Image tradethehalt Posted - 1 month ago

Mid-Day Top 5 Gainers Report: $MRIN (151%) $ADIL (68%) $JAGX (47%) $ORGS (44%) $WNW (26%) If we missed a split/reverse split, let us know!

User Image TheTradeXchange Posted - 1 month ago

$ORGS - Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility

User Image Stock_Titan Posted - 1 month ago

$ORGS Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility https://www.stocktitan.net/news/ORGS/germfree-and-orgenesis-announce-asset-purchase-and-strategic-uppafyxhfwd9.html

User Image techvested Posted - 1 month ago

$ORGS these fuckers are gonna do it... $1.

User Image techvested Posted - 1 month ago

$ORGS put in play money on the chance it gets to $1, clears up overhang. Don't know where from there.

Analyst Ratings
Benchmark Speculative Buy Jun 14, 23
Benchmark Buy Mar 22, 23
Benchmark Speculative Buy Sep 26, 19
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Caplan Vered Chief Executive Offi.. Chief Executive Officer Jan 28 Option 0.012 278,191 3,338 278,191 02/02/22